Cargando…

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients

BACKGROUND: Despite improved treatment of myocardial infarction (MI), real-world patients still suffer substantial risk for subsequent cardiovascular events. Little is known about coagulation activity shortly after MI and whether coagulation activity markers may identify patients at increased risk d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christersson, Christina, Lindahl, Bertil, Berglund, Lars, Siegbahn, Agneta, Oldgren, Jonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810226/ https://www.ncbi.nlm.nih.gov/pubmed/29299952 http://dx.doi.org/10.1080/03009734.2017.1407849

Ejemplares similares

Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease
por: Jönelid, Birgitta, et al.
Publicado: (2019)

Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome
por: Christersson, Christina, et al.
Publicado: (2022)

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
por: Wallentin, Lars, et al.
Publicado: (2013)

Pregnancy Complications and Risk of Cardiovascular Disease Later in Life: A Nationwide Cohort Study
por: Täufer Cederlöf, Elin, et al.
Publicado: (2022)

Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial
por: Hjort, Marcus, et al.
Publicado: (2022)

Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome
por: Batra, Gorav, et al.
Publicado: (2019)

Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery
por: Hammar, Per, et al.
Publicado: (2015)

Do self-reported pregnancy complications add to risk evaluation in older women with established cardiovascular disease?
por: Cederlöf, Elin Täufer, et al.
Publicado: (2019)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
por: Hijazi, Ziad, et al.
Publicado: (2017)

Treatment and Prognosis of Myocardial Infarction Outside Cardiology Departments
por: Gard, Anton, et al.
Publicado: (2020)

Impact of clinical diagnosis of myocardial infarction in patients with elevated cardiac troponin
por: Gard, Anton, et al.
Publicado: (2023)

Prognostic Utility of Soluble TREM‐1 in Predicting Mortality and Cardiovascular Events in Patients With Acute Myocardial Infarction
por: Wang, Yun Kai, et al.
Publicado: (2018)

Sensitive and Specific Detection of Platelet-Derived and Tissue Factor–Positive Extracellular Vesicles in Plasma Using Solid-Phase Proximity Ligation Assay
por: Thulin, Åsa, et al.
Publicado: (2018)

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response
por: Khandagale, Avinash, et al.
Publicado: (2022)

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation
por: Pol, Tymon, et al.
Publicado: (2021)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?
por: Eggers, Kai M, et al.
Publicado: (2021)

Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry
por: Eggers, Kai M., et al.
Publicado: (2021)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
por: Batra, Gorav, et al.
Publicado: (2017)

Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013
por: Mohammad, Moman A, et al.
Publicado: (2018)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
por: Andell, Pontus, et al.
Publicado: (2015)

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
por: Mohammad, Moman A, et al.
Publicado: (2020)

Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)
por: Nordenskjöld, Anna M., et al.
Publicado: (2019)

Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden
por: Johannesen, Kasper, et al.
Publicado: (2023)

GRACE 2.0 Score for Risk Prediction in Myocardial Infarction With Nonobstructive Coronary Arteries
por: Eggers, Kai M., et al.
Publicado: (2021)

Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer
por: Eriksson, Oskar, et al.
Publicado: (2016)

Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
por: Eggers, Kai M, et al.
Publicado: (2021)

Unrecognized myocardial infarction assessed by cardiac magnetic resonance imaging is associated with adverse long-term prognosis
por: Nordenskjöld, Anna M., et al.
Publicado: (2018)

The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction – from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC)
por: Mair, Johannes, et al.
Publicado: (2022)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
por: Johansson, Åsa, et al.
Publicado: (2015)

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006–2019: a registry-based cohort study
por: Leosdottir, Margret, et al.
Publicado: (2023)

Repeated measures of body mass index and waist circumference in the assessment of mortality risk in patients with myocardial infarction
por: Berglund, Lars, et al.
Publicado: (2019)

Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging – Prognostic Implications
por: Nordenskjöld, Anna M., et al.
Publicado: (2016)

Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients
por: Ambroziak, M., et al.
Publicado: (2019)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Influence of health-related quality of life on time from symptom onset to hospital arrival and the risk of readmission in patients with myocardial infarction
por: Henriksson, Catrin, et al.
Publicado: (2014)

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
por: Bolland, Mark J, et al.
Publicado: (2010)

Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ue1fq5cpnubpluup6k42hr29o2